[PDF][PDF] Visualizing engrafted human cancer and therapy responses in immunodeficient zebrafish
…, MN Karabacak, JA Fletcher, DC Sgroi, JA Iafrate… - Cell, 2019 - cell.com
Xenograft cell transplantation into immunodeficient mice has become the gold standard for
assessing pre-clinical efficacy of cancer drugs, yet direct visualization of single-cell …
assessing pre-clinical efficacy of cancer drugs, yet direct visualization of single-cell …
Preferential expansion upon boosting of cross-reactive “pre-existing” switched memory B cells that recognize the SARS-CoV-2 Omicron variant Spike protein
…, A Moormann, A Marshak-Rothstein, JA Iafrate… - medRxiv, 2022 - medrxiv.org
In previously unvaccinated and uninfected individuals, non-RBD SARS-CoV-2 spike-specific
B cells were prominent in two distinct, durable, resting, cross-reactive, “pre-existing” …
B cells were prominent in two distinct, durable, resting, cross-reactive, “pre-existing” …
Metastatic Breast Cancer With ESR1 Mutation: Clinical Management Considerations From the Molecular and Precision Medicine (MAP) Tumor Board at …
A Bardia, JA Iafrate, T Sundaresan, J Younger… - The …, 2016 - academic.oup.com
The last decade in oncology has witnessed impressive response rates with targeted
therapies, largely because of collaborative efforts at understanding tumor biology and careful …
therapies, largely because of collaborative efforts at understanding tumor biology and careful …
Heterogeneous immunogenicity of SARS-CoV-2 vaccines in cancer patients receiving radiotherapy
The immunogenicity of SARS-CoV-2 vaccines in cancer patients receiving radiotherapy is
unknown. This prospective cohort study demonstrates that anti-SARS-CoV-2 spike antibody …
unknown. This prospective cohort study demonstrates that anti-SARS-CoV-2 spike antibody …
[HTML][HTML] Clinical grade “SNaPshot” genetic mutation profiling in multiple myeloma
…, N Horick, D Borger, D Finkelstein, JA Iafrate… - …, 2015 - thelancet.com
Whole genome sequencing studies have identified several oncogenic mutations in multiple
myeloma (MM). As MM progresses, it evolves genetically underscoring the need to have …
myeloma (MM). As MM progresses, it evolves genetically underscoring the need to have …
A one-tube assay for simultaneous detection of gene mutation, fusion, copy number alteration and expression
There are growing demands for tumor genotyping in the clinic, with an ever-growing number
of mutation/fusion targets and expression profiles needed for tumor diagnostics. We sought …
of mutation/fusion targets and expression profiles needed for tumor diagnostics. We sought …
Detection and characterization of circulating tumor cells in localized and metastatic prostate cancer patients using CTC-Chip microfluidic technology
Despite recent molecular advances, the treatment of localized and metastatic prostate cancer
has changed little in recent decades and it remains a major cause of cancer deaths in men…
has changed little in recent decades and it remains a major cause of cancer deaths in men…
Anchored multiplex PCR for detection of gene rearrangements and mutations using next-generation sequencing.
…, D Panditi, H Robinson, JA Engelman, JA Iafrate… - Cancer Research, 2013 - AACR
We describe a rapid targeted RNA-seq library construction method for the detection of gene
fusions in cancer using next generation sequencing. The method involves ligation of half-…
fusions in cancer using next generation sequencing. The method involves ligation of half-…
[PDF][PDF] Clinical Grade “SNaPshot” Genetic Mutation Profiling in Multiple Myeloma
D Finkelstein, JA Iafrate, N Raje - 2014 - cyberleninka.org
Massachusetts General Hospital Cancer Center, Boston, MA, United States Harvard Medical
School, Boston, MA, United States abstract articleinfo
School, Boston, MA, United States abstract articleinfo
Pigmentation status as a Prognostic Biomarker for Survival in Mucosal Melanoma
…, L Ritterhouse, J Lennerz, JA Iafrate - Laryngo-Rhino …, 2023 - thieme-connect.com
Background Mucosal melanoma (MM) is a rare, aggressive subtype of melanoma with
limited therapeutic options and a dismal clinical outcome. Systemic treatments and predictive …
limited therapeutic options and a dismal clinical outcome. Systemic treatments and predictive …